| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000225235.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.025666404 |
Resistant |
| ENSG00000225235.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.025056559 |
Resistant |
| ENSG00000225235.1 |
Cytarabine |
Sarcoma |
0.047470468 |
Sensitive |
